- Constellation Brands maintains its fiscal year comparable EPS forecast between $11.20 and $11.90.
- Projected enterprise net sales growth is set between -1% to 1%.
- Beer, as well as wine and spirits, net sales growth is also expected to range from -1% to 1%.
- Operating cash flow is anticipated to be between $2.4 billion and $2.5 billion.
- Free cash flow estimation ranges from $1.6 billion to $1.7 billion.
- Capital expenditure is projected to be approximately $800 million.
- Second-quarter comparable EPS reported at $3.32, decreasing from $3.63 year-over-year.
- Second-quarter comparable net sales achieved $2.63 billion, reflecting a 6.1% increase year-over-year.
- Beer net sales recorded at $2.47 billion, surpassing expectations.
- Wine and spirits net sales amounted to $159.4 million, exceeding projections.
- Comparable operating profit stood at $897 million, a rise of 1.2% year-over-year.
- Beer operating income reached $964.2 million, a 1.3% increase year-over-year.
- Wine and spirits operating income improved significantly to $6.10 million from a loss last year.
- Beer shipment volume increased by 5.5%, while beer depletion volume slightly decreased by 0.6%.
- Wine and spirits depletion volume saw a significant increase of 10.2%.
- Wine and spirits shipment volume grew by 15.4%.
- The company declared a quarterly cash dividend of $1.03 per share.
- Analyst ratings include 14 buys, 9 holds, and 2 sells.
“`
Constellation Brands on Smartkarma
Analysts on Smartkarma, like Baptista Research, are closely monitoring Constellation Brands. In a recent report titled “Constellation Brands Isn’t Just Selling Beer—It’s Tracking A Key U.S. Demographic!”, they highlighted critical insights. The report emphasizes that while Constellation Brands‘ positive financial results pleased the market, the real excitement stemmed from the management’s comments. Constellation Brands is observing a resurgence in its core Hispanic beer consumer segment, showing signs of increased purchasing activity. Since a significant portion of the company’s beer business is linked to Hispanic consumers, these developments are seen as a crucial indicator of consumer health within this demographic.
Baptista Research‘s bullish sentiment towards Constellation Brands suggests optimism about the company’s prospects. The report underscores the importance of recent brand and regional trends for Constellation Brands, showcasing the firm’s sensitivity to shifts in consumer behavior within the key demographic of Hispanic consumers. This level of detailed analysis provided by independent analysts on Smartkarma offers valuable insights for investors looking to understand the nuanced dynamics impacting companies like Constellation Brands.
A look at Constellation Brands Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Constellation Brands, a leading producer and marketer of alcoholic beverages with a diverse portfolio of brands, is positioned favorably for long-term growth. Smartkarma’s Smart Scores indicate a positive outlook for the company, with strong ratings in areas such as Dividend and Growth. This suggests Constellation Brands is well-equipped to generate good returns for investors over time.
While the Value, Resilience, and Momentum scores are not as high as Dividend and Growth, Constellation Brands‘ overall Smart Scores paint a promising picture for the company’s future performance. With a strategic focus on wine, imported beer, and distilled spirits, Constellation Brands stands out as a resilient player in the market with potential for continued expansion and success in the industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
